Copy
HRA Latest - 3 September 2020
Welcome to HRA Latest! 

I’m pleased to be able to share this month’s news and updates for all those working or involved in health and social care research. 

Today we’re asking for your help as we recruit volunteer lay members to join our Confidentiality Advisory Group (CAG). We’re looking for members with experience of healthcare as a patient, a carer or a professional, and with some experience of working with data. Is this you or someone you know?

There’s more on this, and all of our stories, below. 

Don’t forget, for regular updates and the latest news, you can follow us on Twitter @HRA_Latest. 

Teresa Allen, Chief Executive
Join our Confidentiality Advisory Group 
We’re recruiting volunteer lay members to join our Confidentiality Advisory Group (CAG). CAG meets regularly to assess applications to use healthcare data and provides independent expert advice to the HRA and the Secretary of State for Health. We’re looking for members with experience of healthcare as a patient, a carer or a professional, and with some experience of working with data.
Read more
COVID-19 study planning
If you're planning a COVID-19 research study, please visit our website first to check if similar studies have been approved, to avoid duplication of research. We aim to publish research summaries for COVID-19 studies within three days of approval, so the information is up to date. 
 
Read more
Health and social care research projects for educational purposes
As the lockdown eases, we want to update students, supervisors and higher education institutions (HEIs) on our current position on student research and ethics review. 
Read more
ARSAC changes
On Wednesday 2 September, ARSAC (the Administration of Radioactive Substances Advisory Committee) launched an online portal to apply for approval of new research studies.
Read more
Make it Public  our new transparency strategy
We launched our new strategy in July, and work continues to ensure information about all health and social care research – including COVID-19 research – is made publicly available to benefit patients, researchers and policy makers. If you’ve not had chance to look at the strategy in detail, you can read it in full on our website. For a reminder about why the strategy is important, we have a five-minute video for you to watch.
Read more
Podcast series on complex innovative design trials
The HRA has teamed up with the National Institute for Health Research (NIHR) and the Experimental Cancer Medicine Centre (ECMC) to produce a series of 11 podcasts looking at Complex Innovative Design (CID) trials. The podcasts explore innovative trial design and delivery and look at changes to the clinical research landscape as clinical trials evolve to find new, faster and more efficient ways to bring new treatments to patients.
Read more
Pharmacy Assurance accepting new study types from end of September 
We are pleased to announce that from Wednesday 30 September 2020, the HRA will accept Phase I and II non-oncology CTIMPs through the Pharmacy Assurance process. This means that from this date, all eligible Phase I-III CTIMPS taking place in secondary care in the NHS, can be processed through Pharmacy Assurance.
Read more
COVID-19 research and the future
Our non-executive director, Dr Nicole Mather, has written an opinion piece in Nature about the factors which enabled COVID-19 research to be accelerated, as well as some of the lessons we can learn to help streamline future clinical trials and deliver effective treatments. 
Read more
New Chair for the MHRA
Stephen Lightfoot has been appointed as the new Chair of the Medicines and Healthcare products Regulatory Agency. 
Stephen has been a Non-Executive Director of the Agency since September 2015 and is also Deputy Chair of Sussex Community NHS Foundation Trust and Non-Executive Chair of Sussex Primary Care Limited. We would like to congratulate Stephen and wish him all the best in his new role. 
Read more
EU exit information
The MHRA has published new guidance to help researchers and research sponsors prepare for the UK’s transition to a new relationship with the EU from 1 January 2021. 
Read more
Twitter
Website
Copyright © 2020 Health Research Authority, All rights reserved.
You are receiving this newsletter because you have subscribed.

Our mailing address is:
Health Research Authority
Skipton House, 80 London Road
London, E5 8TT
United Kingdom

Add us to your address book

Want to change how you receive these emails?
You can update your preferences or unsubscribe from this list.






This email was sent to <<Email Address>>
why did I get this?    unsubscribe from this list    update subscription preferences
Health Research Authority · Skipton House, 80 London Road · London, E5 8TT · United Kingdom